Delivery Order SPE2DB22D1202-SPE2DB24FUHL1
- Not listed
- This federal contract award, valued at $1,401.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of 4554758291 - Celecoxib 200 mg Capsules, in packages of 500, with an ultimate completion date of September 14, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,298.08 firm fixed-price delivery order is for the supply of 4,565,092,057 Celecoxib 200 mg capsules. The contract has a period of performance through July 10, 2024 and does not include a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,826.32, is a delivery order for the supply of Celecoxib 200 mg capsules. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $1,050.78, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of Celecoxib 200mg medication, a non-set-aside requirement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award, valued at $3,558.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,938,793 units of Celecoxib 100 mg capsules, a pharmaceutical product, to support various government healthcare programs and federal facilities. This award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been...
- This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQEVU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,434.56 firm fixed-price delivery order is for the supply of 4568142809 Celecoxib 200 mg capsules, and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,674.63, is for the delivery of Celebrex 200 mg capsules to support military healthcare programs. It is a firm-fixed price delivery order contract with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,716.28 delivery order is for the supply of Celecoxib 400 mg capsules, a pharmaceutical product. The contract has a firm fixed price and no set-aside requirement, indicating full and open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $1,748.42, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Celecoxib 200mg, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly...
- Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp on October 18, 2023. The $293 firm fixed price order is for 500 capsules of the generic drug celecoxib 200 mg. Performance will occur at the contractor's facility located in Conshohocken, Pennsylvania, with an expected completion date of October 19, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, operating as the prime and only contractor....
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUHL1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,197.61, is for the delivery of 4,562,868,648 capsules of the medication Celecoxib 200 mg. This is a firm fixed-price delivery order contract with an ultimate completion date of November 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/20/23 |